PropertyValue
?:abstract
  • The outbreak of COVID-19 pandemia is a major health worldwide concern. Patients with cancer might have a worse outcome, because of the immunosuppression determined by the tumor itself and anti-cancer treatments, including chemotherapy and radiotherapy. The impact and course of viral infection in patients receiving immunotherapy remains unknown. We report the case of a patient with metastatic melanoma, long responder to anti PD-1 blockade who got infected with Sars CoV-2, recovering without sequelae. A critical review of literature was performed. Limited data available in literature support the possibility to continue the immunotherapy in patients with cancer under control.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1080/07357907.2020.1844893
?:journal
  • Cancer_investigation
?:license
  • unk
?:pmid
?:pmid
  • 33125301.0
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • Course of Sars-CoV2 infection in patients with cancer treated with anti-PD-1: a case presentation and review of the literature.
?:type
?:year
  • 2020-10-30

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/5nid0c1c>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/5nid0c1c>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all